Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.
Authors
Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Sukumaran, A; Loyse, N; Bharwani, N; Rockall, AURI
http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/2514http://qmro.qmul.ac.uk/xmlui/handle/123456789/12316
